This report describes pituitary adenoma 1, multiple types (PITA1) which is a subtype of pituitary adenoma (also known as familial isolated pituitary adenoma, FIPA); PITA1 exhibits autosomal dominant inheritance. The human gene implicated in this disease is AIP (aryl hydrocarbon receptor interacting protein), which forms a complex with the ligand-activated transcription factor AHR. There is a single orthologous gene in Drosophila, CG1847, for which an amorphic allele resulting from imprecise excision of an insertion, RNAi targeting constructs, and an allele caused by insertional mutagenesis have been generated Dmel\CG1847 is also orthologous to a second gene in human, AIPL1.
UAS constructs of the human Hsap\AIP have been introduced into flies, including wild-type and variant forms implicated in PITA1. Heterologous rescue (functional complementation) using the wild-type human gene has been demonstrated for the amorphic CG1847 lethal phenotype. Candidate disease-associated missense variants have been assessed for ability to rescue. Variant(s) implicated in human disease tested (as transgenic human gene, AIP): the I13N, W73R, G272D, and C238Y variant forms of the human gene have been introduced into flies and fail to rescue the lethal phenotype. Other variants tested showed rescue and are thus postulated to be non-pathogenic, including R16H, Q164R, E293V, A299V, R304Q, R314W and R325Q.
Animals homozygous or hemizygous for an amorphic allele of Dmel\CG1847 die at an early larval stage.
[updated Dec. 2018 by FlyBase; FBrf0222196]
[PITUITARY ADENOMA 1, MULTIPLE TYPES; PITA1](https://omim.org/entry/102200)
[ARYL HYDROCARBON RECEPTOR-INTERACTING PROTEIN; AIP](https://omim.org/entry/605555)
AIP gene mutations account for approximately 15 to 25 percent of cases of familial pituitary adenoma (FIPA). Somatotropinomas (pituitary adenomas characterized by excessive production of growth hormone) are the most common type of tumor in these individuals. The tumors usually occur at a younger age, often in childhood, and are larger than FIPA tumors not caused by AIP gene mutations. [Genetics Home Reference, Familial isolated pituitary adenoma; 2018.12.14]
Pituitary adenomas are benign monoclonal neoplasms of the anterior pituitary gland, accounting for approximately 15% of intracranial tumors. Growth hormone-secreting adenomas, also known as somatotropinomas, which clinically result in acromegaly (coarse facial features, protruding jaw, and enlarged extremities), comprise about 20% of all pituitary tumors and are the second most common hormone-secreting pituitary tumor after prolactin-secreting tumors, which account for 40 to 45% of pituitary tumors. ACTH-secreting tumors, which result in Cushing disease, and thyrotropin-secreting tumors are much less common. Nonsecreting pituitary tumors, which account for about 33%, can cause symptoms due to local compressive effects of tumor growth (Vierimaa et al., 2006, pubmed:16728643; Georgitsi et al., 2007, pubmed:17360484; Horvath and Stratakis, 2008, pubmed:18200440). [from MIM:102200; 2018.12.14]
AIP-related isolated familial pituitary adenoma (AIP-related FIPA) is defined as the presence of an AIP germline pathogenic variant in an individual with a pituitary adenoma (regardless of family history). [Gene Reviews, AIP-Related Familial Isolated Pituitary Adenomas; 2018.12.14]
Multiple types of pituitary adenoma (PITA1) are caused by heterozygous mutation in the aryl hydrocarbon receptor-interacting protein gene (AIP). Mutations in the AIP gene have been found predominantly in growth hormone (GH)-secreting adenomas, but have also been found in adrenocorticotropic hormone (ACTH)-secreting, thyroid hormone (TSH)-secreting, and prolactin (PRL)-secreting pituitary tumors. [from MIM:102200; 2018.12.14]
AIP (Aryl Hydrocarbon Receptor Interacting Protein) encodes a receptor for aryl hydrocarbons that acts as a ligand-activated transcription factor (AHR). The AIP protein is found in the cytoplasm as part of a multiprotein complex, but upon binding of ligand is transported to the nucleus. This protein can regulate the expression of many xenobiotic metabolizing enzymes. The AIP protein can also bind specifically to and inhibit the activity of hepatitis B virus. [Gene Cards, AIP; 2018.12.14]
Many to one: 2 human to 1 Drosophila; the second human gene is AIPL1.
High-scoring ortholog of human AIP and AIPL1 (1 Drosophila to 2 human). Dmel\CG1847 shares 37-39% identity and 59-60% similarity with the human genes.